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Abstract: Resin-based dental restorative materials are extensively used today in dentistry. 
However, significant concerns still remain regarding their biocompatibility. For this 
reason, significant scientific effort has been focused on the determination of the molecular 
toxicology of substances released by these biomaterials, using several tools for risk 
assessment, including exposure assessment, hazard identification and dose-response 
analysis. These studies have shown that substances released by these materials can cause 
significant cytotoxic and genotoxic effects, leading to irreversible disturbance of basic 
cellular functions. The aim of this article is to review current knowledge related to dental 
composites’ molecular toxicology and to give implications for possible improvements 
concerning their biocompatibility. 
Keywords:  dental composite resins; molecular toxicology; biocompatibility; 
biodegradation; cytotoxicity; genotoxicity 
Abbreviations:  ALP = Alkaline Phosphatase; Bis-GMA  =  2,2-bis[4-(2-hydroxy-3-
methacryloxypropoxy)phenyl]propane); BP=Benzoyl Peroxide; BPA = Bisphenol A; BrdU 
= 5-bromo-2’-deoxyuridine; CCCP = carbonylcyanide m-chlorophenylhydrazone; CMF-
DA  =  Chloromethylfluorescein diacetate; CQ =  camphorquinone; DCFH-DA =  2’,7’-
dichlorofluorescein diacetate; DMA = 2-dimethylaminoethyl methacrylate; DMABEE = 
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4-N,N-Dimethylaminobenzoic acid ethylester; DMT=N,N-dimethyl-p-toluidine; EMSA = 
Electromobility shift assay; FACs =  Flow cytometry; GSH =  Glutathione; HEMA = 
2-hydroxyethylmethacrylate; HMBP = 2-hydroxy-4-methoxybenzophenone; LPS = lipo-
polysaccharide;  MBBr = monobromobimane; mBCl  =  monochlorobimane; MTT = 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliombromide; NAC = N-acetylcysteine; PI 
= propidium-iodide; PI3-Kinase = phosphatidylinositol 3 kinase; ROS = Reactive Oxygen 
Species; S9 mix =  metabolically active microsomal fraction from mouse or rat liver;   
SDS-PAGE electrophoresis = Sodium Dodecyl Sulfate Polyacrylamide gel electrophoresis; 
SEM = Scanning Electron Microscopy; TBARS = Thiobarbituric acid reactive substances; 
TEGDMA  =  triethyleneglycoldimethacrylate; TUNEL assay =  terminal deoxyribo-
nucleotidyl transferase (TdT) uridine triphosphate; (UTP) nick-end labeling; UDMA = 
urethanedimethacrylate; WB = Western blotting; WST-8 = [2-(2-methoxy-4-nitrophenyl)-
3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt] 
 
1. Introduction 
 
The development and widespread use of new generations of resin-based dental restorative materials 
has allowed for the application of more conservative, esthetic and long lasting restorative techniques. 
These adhesive techniques are extensively used in a wide variety of applications in dentistry, including 
restorative procedures, prosthodontics, orthodontics and preventive dentistry, making resin-based 
composites one of the most important groups of materials in dental practice. The main bulk of 
scientific and manufacturing effort during the past years has been focused on the improvement of the 
filler fraction of these materials, providing a great variety of new formulations in the micro- or   
nano-scale, in an attempt to improve their mechanical and esthetic properties. On the other hand, little 
improvement has been offered with respect to the resinous matrix of these materials, which is based in 
the majority of commercially available products on methacrylate monomers. Most of these products 
consist of a mixture of various methacrylate monomers, such as BisGMA (2,2-bis[4-(2-hydroxy-3-
methacryloxypropoxy)phenyl]propane) and UDMA (urethane dimethacrylate) in combination with co- 
monomers of lower viscosity, such as TEGDMA (triethyleneglycol dimethacrylate), EGDMA 
(ethyleneglycol dimethacrylate) or DEGDMA (diethyleneglycol dimethacrylate) [1-3]. These 
methacrylate monomers, polymerized through radical chain polymerisation, are responsible for major 
clinical disadvantages, such as polymerization shrinkage of the composites, leading to microleakage 
phenomena in the tooth-material interface [4,5], as well as adverse effects caused by substances 
released from the resinous matrix due to incomplete polymerization or resin degradation [6-9]. Several 
attempts have been made in order to overcome these problems through the development of new 
monomer systems, including the so called “expanding monomers”, based on spiro-orthocarbonate 
molecules [10], epoxides systems (oxiranes, siloranes) set via cationic polymerization [11,12], or 
multifunctional hyper-branched methacrylic monomers (dendrimers), as alternatives to the 
conventional methacrylic formulations [13-15]. However, the insufficient mechanical properties of 
these systems, together with several problems concerning their filler incorporation and polymerization 
have not yet allowed for their extensive clinical application.  Int. J. Mol. Sci. 2009, 10                 
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The release of methacrylic monomers together with compounds of the polymerization system from 
dental composites has been considered as a source of a wide variety of adverse biological reactions, 
including local and systemic toxicity, pulp reactions, allergic and estrogenic effects. These effects have 
been extensively reviewed in the literature [16-21]. On the other hand, a significant amount of 
scientific effort has been focused during the past few years by several research groups in the world on 
the determination of the molecular mechanisms underlying the dental composites’ toxicological effects 
(cytotoxicity and genotoxicity). These studies have used a variety of sophisticated molecular biological 
techniques in order to assess the potential risks that these chemicals could pose to the living tissues, 
including exposure assessment, hazard identification, dose-response analysis, analysis of signaling 
pathways implicated in tissue response and repair and genotoxicity analysis, as a tool for potential 
mutagenic and clastogenic effects. This rapidly growing field of molecular toxicology of substances 
released by dental restorative materials also reflects the expanding public awareness of potential health 
risks caused by these materials during their long term clinical services and the urgent need for 
improvement on their biological properties. Therefore, the aim of this article is to review the rapidly 
growing body of knowledge related to dental composite materials’ molecular toxicology and to give 
implications for possible future improvements with respect to their biocompatibility.  
 
2. Nature, Amount and Bioavailability of Substances Released by Resin–Based Dental 
Restorative Materials 
 
Dental composite resin materials contain polymer networks that have been shown to be susceptible 
to hygroscopic and hydrolytic effects to varying extents, dependent upon their chemistry and structure. 
These effects may not only affect their physical and mechanical properties leading to a shortened 
service life but they may also be responsible for short-term release of unreacted components, as well as 
long-term elution of degradation products in the oral cavity [8,16,22,23].  
The elution of unreacted components from dental composites is influenced by several factors, 
including the chemistry of the composite (mainly the solubility and the molecular weight of the 
monomers used), the degree of conversion, the degree of crosslinking of the polymer network, the 
surface treatment of the filler particles and the nature of the solvent [7,23-26]. The free radical 
polymerization of dimethacrylate monomers produces a highly crosslinked polymer network, but also 
leaves unreacted monomers or oligomers. For most resin-based composites the degree of conversion 
has been reported to vary from 55 to 75 % when they are directly cured by halogen or LED curing 
units [26-32] and can reach up to 80% when the composite resins are further post-cured indirectly 
under different laboratory conditions, including high intensity light, heat, pressure or a combination of 
the above [33-35]. On the other hand, the degree of conversion can be as low as 25-35% if oxygen is in 
contact with the resin surface during the setting reaction (oxygen inhibition layer), allowing for more 
unreacted components to being released from the polymer network [24,36]. The latter may constitute a 
significant biological risk.  
The nature and amount of released components has been evaluated by several elution studies, using 
a variety of techniques, including Ultraviolet (UV) and Infrared (IR) Radiation, High Performance 
Liquid Chromatography (HPLC) and Gas Chromatography/Mass Spectroscopy (GC/MS) [6,8,36-52]. 
These studies have shown that resin-based dental materials are able to release more than 30 different Int. J. Mol. Sci. 2009, 10                 
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compounds into aqueous or organic solvents. These substances include major (co)-monomers, 
additives, compounds of the polymerization system (co initiators, stabilizers, or inhibitors), as well as 
ions form the filler particles. Most of the above mentioned studies support that almost any component 
present in a composite or adhesive resin is capable of being leached from the set material [42,49]. 
Generally, extraction is more complete in alcohol or organic solvents as compared to water. Moreover, 
solution of 75% ethyl alcohol in water, which is recommended by US FDA as a food/oral simulating 
liquid, has been shown to be among the best solvents for dental composite networks, although this 
solution extracts far more organic compounds, as compared to the artificial saliva that is composed of 
a complex salt mixture [6,53,54]. However, there are a few components that are also leached into an 
aqueous media. In particular, considerable amounts of TEGDMA and HEMA may be released by 
polymerized composite resins into water. Bis-GMA, UDMA, TEGDMA, EGDMA DEGDMA,   
1,6-hexanediol di-methacrylate, methyl methacrylate, camphoroquinone, 4-N,N-dimethylaminobenzoic 
acid, ethyl ester, and various other substances have been also identified in minor concentrations in 
aqueous extracts [16,42,44,45,50,54]. In filled polymers, ions from the filler particles may also be 
released. These include strontium, silicon, boron, sodium and barium, depending on the filler   
type [55,56]. 
It is important to note that not all unreacted methacrylate groups in resin-based materials are 
capable of being leached into aqueous environment, because they are part of dimethacrylate molecules 
covalently bound to one end of the main polymer chain. It has been reported that approximately 10% 
or less of the nonreacted methacrylate groups exist as residual monomer and are available to be 
leached into various media [6,57]. Studies have shown that elution of as little as 0.05% to as high as 
2.0 % of the weight of the specimen into aqueous media, with elution into alcohol and other organic 
solvents being generally higher (2-6%) [6,8,41,46,57]. In most cases, the elution process is completed 
within the first few days or weeks after initial polymerization depending on the solvent [23,53,58]. 
Among the resinous monomers released, hydrophilic monomers, such as TEGDMA, were identified in 
higher amounts into aqueous extraction media (0.04-2.3%wt) as compared to BisGMA (0.03-0.07%) 
[19,24,42,59,60]. Moreover, the hydrophilic monomers HEMA and TEGDMA were the only ones to 
be able to diffuse through the dentin into the pulp space at significantly high concentrations in the 
millimolar range. The diffusion increases when the remaining dentin thickness is decreased, especially 
below 1mm or after acid etched treatment [61]. HEMA leaching from dental adhesives might reach 
concentrations as high as 1.5-8 mmol/L in the pulp [62], whereas TEGDMA concentrations could be 
in the range of 4 mmol/L [20,63]. These concentrations may be high enough to cause detrimental 
effects to the pulpal homeostasis and repair [8,17,20].  
The amount of leachable components from composite resin networks has been found to be affected 
by the curing protocol and the density of crosslinking of the polymer network produced. However, a 
complex relationship exists between these two parameters and the extent that the elution process takes 
place. It is generally accepted that highly crosslinked polymers are more resistant to degradative 
processes, based on the more limited space and pathways available for solvent molecules to diffuse 
within the structure [23,64]. On the contrary, some other studies support that the higher the 
crosslinking density of a resin, the higher its heterogeneity and the larger the volume of micropores. 
This increase of the heterogeneity of the resin network enhances the elution process of the resin 
monomers [25,65]. These studies support that other factors, including the degree of conversion of the Int. J. Mol. Sci. 2009, 10                 
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polymer and the quantity of pendant molecules existing within the network, may also affect the extent 
of water sorption and monomer elution. 
Most studies also support that the elution from light-curing polymer-based materials is mainly 
influenced by the amount of energy delivered to the material during irradiation. The higher the energy 
density applied, the lower the elution into various solvents [46,66,67]. This can be explained by the 
increase in the degree of conversion with increasing energy density. However, for a given energy 
density, different combinations of curing time, power density and modes of cure (continuous,   
pulse-delay, or stepped) may significantly affect the elution process. Munksgaard et al. [46] observed 
that specimens cured with plasma arc for 3 s eluted a higher amount of monomers compared to 
specimens cured for 40 s with a conventional quartz–tungsten–halogen curing unit. Hofmann et al. 
[68] observed that different curing protocols influenced the solubility and water sorption of resin 
composites. Moon et al. [66] recorded different degrees of elution and softening in ethanol when a 
resin composite was cured with various curing units and curing protocols. Yap et al. [24] proved that 
with the same emitted energy level, the level of crosslinking of resin composites irradiated with 
continuous mode halogen curing is higher than LED-cured analogs. This is accompanied by more 
leached monomer and more pronounced toxic effects. Bennetti et al. [67] also found that the curing 
mode (continuous, step cured or pulse-delay mode) can significantly affect the crosslinking and degree 
of conversion of the material and therefore the process of elution. Therefore, it can be concluded from 
the above mentioned studies that the elution of elements and the degree of cytotoxicity of composite 
resins depends on the mode of polymerization process, including type of curing unit, total energy 
density, power density, irradiation time and mode of curing (continuous or different modes of soft start 
curing) [24,26,69].  
 
3. Degradation of Resin–Based Dental Restorative Materials 
 
As already mentioned, elution of substances from resin composites is usually completed within a 
few hours or days after initial polymerization. However, leachable substances may also be generated 
by erosion and degradation over time. The latter is of major biological significance, as it theoretically 
lasts as long as the service life of the material [6,16,22,54]. Resin degradation may be caused by photo, 
thermal, mechanical, or chemical influences. For example, it has been found that biologically derived 
enzymes, such as cholesterol esterase (CE) and pseudocholinesterase (PCE) can degrade the monomer 
components of composite resins, which may then result in the liberation of methacrylic substances 
[7,70]. Reviews of polymer degradation mechanisms have been already published [7,22]. 
Methacrylates degradation can produce different types of products through different mechanisms, such 
as formaldehyde via oxidation and methacrylic acid and other molecules, such as bis-HPPP, which is 
the dialcohol left after splitting methacrylic acid from bis-GMA by hydrolysis or esterification 
[23,41,71-74]. Other biodegradation products also include triethylene glycol methacrylate (TEGMA), 
2,3-epoxymethacrylic acid (2,3-EMA) and ethoxylated bisphenol A (E-BPA) [75,76]. The 
biodegradation process mainly depends on the molecular chemistry. TEGDMA has been shown to be 
more susceptible to enzymatic hydrolysis than Bis-GMA or Bis-EMA [71,77]. Moreover, chemically 
modified BisGMA (ethoxylated BisGMA) degrades to a lesser degree in the presence of cholesterol 
esterase as compared to BisGMA. In addition, urethane modified bis-GMA/TEGDMA networks have Int. J. Mol. Sci. 2009, 10                 
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been shown to be more stable in the presence of cholesterol esterase than unmodified bis-GMA/ 
TEGDMA networks [74]. It is also important to note that not all esterases have demonstrated the same 
specificity for monomer components. Kinetic studies have shown that PCE preferentially hydrolyzes 
TEGDMA over BisGMA, while CE’s activity with respect to BisGMA is 14 times greater than that of 
PCE [73]. Therefore, it can be concluded that resinous matrix degradation, caused through different 
mechanisms is mainly dependent on the molecular chemistry of the monomers released, as well as the 
enzymatic activity of each individual.  
Little is known however with respect to pharmacokinetics and toxicokinetics of degradation 
products of resin components. The existing studies support that HEMA and TEGDMA monomers 
when administered by different routes (oral, subcutaneously or intravenously) are almost completely 
eliminated 24 hours after administration. The main routes of excretion in animal studies are via the 
lungs and to a lesser extend via the faeces or the urine [78]. This implies that the concentration of these 
monomers in different tissues is below those known to cause acute toxic effects. However, several 
studies support that sub- cytotoxic concentrations of these monomers are able to alter cell function 
[79]. Further investigation is necessary to clarify the in vivo degradation and toxicokinetics of 
substances released by dental composite resins. 
Another very important molecule from a biological point of view is Bisphenol A (BPA), due to its 
well documented estrogenic activity [80-82]. BPA is used in the production of several types of resins 
used in a variety of products including food and drink containers, CDs etc. The majority of published 
studies were not able to identify BPA as a degradation product of BisGMA-based composites, despite 
the fact that several of these studies used extreme elution conditions with respect to pH, organic 
solvents (e.g., acetonitrile) and presence of different hydrolytic enzymes (esterases) [83-87]. On the 
other hand, BPA was found to be eluted as a degradation product of BisDMA, which is commonly 
found as a component of pit and fissure sealants [88-91]. The latter has been considered the main cause 
of their reported estrogenic effects [88,90]. In contrast, however to the abovementioned studies, Pulgar 
et al. [92] reported considerable release of BPA (up to 1.8 μg/mg of resin) and other related aromatic 
compounds with estrogenic effects (Bis-DMA, 1.15 pg/mg), bisphenol A diglycidylether (6.1 pg/mg), 
Bis-GMA (2.0 pg/mg) and ethoxylate and propoxylate of bisphenol A from Bis-GMA-based 
composites. These concentrations have found to be able to cause significant biologic effects in in vivo 
experimental models [80,93-98]. 
BPA has been also detected in the saliva and urine samples of healthy donors immediately after 
composite placement. Arenholt-Bindslev et al. [89] reported that minute amounts of BPA were 
detected in saliva samples collected immediately after, but not 1 h and 24 h after placement of dental 
sealants. Fung et al. [99] also analyzed the blood samples and saliva of a patient population and 
concluded that even if small amount of BPA was present in the saliva immediately after placement of 
the sealant, it could not be detected in their blood samples. Sasaki et al. [100] detected BPA using an 
ELISA system, in the range of several tens to 100 ng/mL in the saliva of healthy donors after filling 
teeth with two pit and fissure sealants. BPA was found however to be removed with sufficient gargling 
after treatment. Joscow et al. [101] found that BPA concentrations in saliva samples of healthy donors 
collected immediately after a BisDMA containing sealant placement were more than 50-fold higher 
than their baseline BPA concentrations, also in the range of several tens of ng/mL, whereas urinary 
concentrations one hour after placement were five times higher than their baseline levels. It can be Int. J. Mol. Sci. 2009, 10                 
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concluded that even if BPA concentration is reduced after resin materials placement these results cause 
significant concerns with respect to the long term exposure to estrogenic substances released by 
composites, especially when it is added to the environmental exposure to several xenoestrogens.  
 
4. Molecular Toxicology of Substances Released by Composite Resins 
 
4.1. Cytotoxicity and Genotoxicity of Released Substances  
 
The cytotoxicity and genotoxicity of substances released by dental composite resins has been 
extensively studied during the last two decades. Most studies have focused on the effects of resin 
compounds on basic cellular functions, such as cell proliferation, inhibition of enzyme activities, 
disruption of cell morphology, membrane integrity, cell metabolism (DNA-, RNA- and protein 
synthesis) and cell viability. These effects have been already reviewed by Geurtsen [16] and Schweikl 
et al. [20]. Most studies have shown that dental composite resins are able to release compounds with 
severe (Bis-GMA, UDMA, TEGDMA, DMBZ, και DMDTA) or medium (HEMA, BEMA, CQ, 
DMPT and DMAPE) cytotoxicity, whereas their biodegradation products, such as methacrylic acid, 
have been shown in general to be less cytotoxic [44,54,62,102,103]. The latter can also explain the fact 
that the cytotoxic effects of these compounds are reduced by the action of a metabolically active 
microsomal liver fraction (S9 mix) [104,105]. Among the substances released, the major 
(co)monomers have been identified as the main cause of cytotoxicity and their TC50 have been 
evaluated in a variety of cell culture systems, including permanent cell lines (3T3 and L929 
fibroblasts, V79 chinese hamster lung fibroblasts, HaCaT keratinocytes, THP-1 monocytes etc), as 
well as primary cell lines of human origin (pulp, periodontal, gingival or skin fibroblasts), presenting 
significant variability in their sensitivity. Despite these differences, in most studies the cytotoxicity 
ranking of the basic monomers has been found to be the following: BisGMA > UDMA > TEGDMA 
>>> HEMA [54,102,104,106,110-113]. Moreover, a relationship between the structural and biological 
activities of the monomers has been reported [114].  
 
4.2. Molecular Mechanisms 
 
Taking a step forward, a considerably growing number of studies has been focused on the 
investigation of the key molecular mechanisms and signaling pathways involved in resin   
components-induced cytotoxicity and genotoxicity. These mechanisms have been already reviewed by 
Schweikl et al. three years ago [20]. However, considerable scientific knowledge during the last few 
years has been added with respect to the molecular toxicology of these substances. The studies relevant 
to the molecular mechanisms underlying the resin components’ induced cytotoxicity and genotoxicity 
are presented in Tables 1 and 2 respectively, mainly focusing on the studies of the last decade, that 
have been conducted in target tissues of the oral cavity. Int. J. Mol. Sci. 2009, 10                 
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Table 1. Mechanisms of cytotoxic effects of substances released by resin-based dental restorative materials. 
Study Substances  studied 
(concentration) 
Cell line  Biological parameters 
assessed 
Methods Main  conclusions 
Geurtsen et 
al. 1998 
[116] 
35 resin composite 
monomers/additives 
Human primary fibroblasts 
from attached gingiva 
(HGF) pulp (HPF) and the 
periodontal ligament 
(HPLF) and 3T3 swiss 
albino mouse fibroblasts 
1. Cytotoxicity  1. Spectrophotometrically 
(Hoechst 33342) 
Within the tested compounds, severe (e.g., Bis-
GMA, UDMA, DMBZ, and DMDTA, BHT, HMBP) 
or moderate (HEMA, BEMA, CQ, DMPT, and 
DMAPE) cytotoxic effects could be recorded. 
Reaction/decomposition products displayed only 
slight effects.  
Rakich et al. 
1999 [153] 
Bis-GMA, UDMA, 
HEMA, 4-META 
Human THP-1 monocytic 
cells  
1. Cytotoxicity 
2. Secretion of II-1b 
&TNF-a (±LPS) 
1. MTT 
2. ELISA  
All monomers decreased LPS-induced release of 
TNFa & IL1-b at TC50 concentrations. 
Li et al. 1999  
[139] 
HEMA Human  Pulp  Fibroblasts 
(HPF) 
1.Cytotoxicity 
2.Cell cycle 
1. MTT  
2. FACs (PI) 
 
HEMA induced dose dependent cytotoxicity and cell 
cycle arrest in G2 phase. 
Bouillaguet 
et al. 2000 
[198] 
HEMA  Human THP-1 monocytic 
cells  
1.Cytotoxicity 
2. Protein synthesis 
Α. Trypan Blue assay 
Β. BCA assay 
HEMA significantly reduced cell proliferation but 
increased mitochondrial activity and protein 
synthesis after long term exposure to subtoxic 
concentrations (0.75 mM) 
Theilig et al. 
2000 [161] 
TEGDMA (0.25-5 mM) 
BisGMA (0.001-0.1 
mM) 
Human gingival fibroblasts 
(HGFs) and HaCaT 
(human keratinocytes) 
1. Cell Proliferation 
2. Cell Migration 
3. Tenascin expression 
1. DNA synthesis (BrdU 
incorporation) 
2. Modified boyden 
chamber assay 
3.Immunocytochemistry 
and spectrophotometry 
Proliferation of both cell types was significantly 
inhibited at concentrations >0.25 mM (TEGDMA) or 
> 0.01 mM (BisGMA). BisGMA (at 0.01 mM) but 
not TEGDMA significantly affected migration of 
keratinocytes and altered the expression of tenascin 
of HGF and HaCaT cultures. Thus, BisGMA may 
influence the healing of injured oral tissues. 
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Table 1. Cont. 
Noda et al. 
2002 [62] 
HEMA (0-40 mM) 
TEGDMA (0—3 mM) 
Human THP-1 monocytic 
cells 
1. Cytotoxicity 
2. Heat Shock protein 72 
expression 
1.MTT 
2. SDS-PAGE Gel 
Electrophoresis & 
Immunoblotting 
HEMA and TEGDMA significantly suppressed heat 
induced HSP72 expression, even at sublethal levels, 
but did not induce HSP72 by themselves. These 
results suggest that these monomers could modulate 
the HSP stress response without altering cellular 
metabolic activity. 
Engelmann 
et al. 2001 
[146] 
TEGDMA (0.5 mM) 
HMBP (0.05mM) 
Mouse 3T3-fibroblasts  1.Metabolic effects  1.NMR spectroscopy  TEGDMA could be detected in all fractions (cytosol, 
lipid fractions and culture media) of 3T3 cells, while 
HMBP was found only in the lipid fraction. 
Additionally, TEGDMA changed the metabolic state 
of cells, indicated by slight decreases of nucleoside 
triphosphates and an increase in the ratio of 
nucleoside diphosphates to nucleoside triphosphates  
Kostoryz et 
al. 2001 
[159] 
BisGMA (0-50 μΜ) 
MAA (0-1,200 μΜ) 
CyracureTM UVR 6105 
(epoxy monomer) (0-800 
μΜ) 
Endothelial cells, ECV 304 
(TNF-a stimulated) 
1.Cytotoxicity 
2. ICAM-1 expression 
1. MTT 
2. FACs (anti–ICAM-1 
antibody) 
Except for UVR 6105, the methacrylates 
significantly decreased ICAM-1 expression in TNF-
a-stimulated cells, which suggest that methacrylates 
may decrease the recruitment of leukocytes to 
inflammation sites.  
Atsumi et al. 
2001 [162] 
CQ, BZ, BP, 9-F 
+DMT 
1. Cell free system 
2. Human gingival 
fibroblast (HGFs) and a 
human epidermoid 
carcinoma cell line from a 
sub-mandibular gland 
tumor.  
1.Production of free 
radicals  
2. Cytotoxicity 
 
1. Spectrophotometrically 
(reduction of DPPH) and 
from the conversion of 
TEGDMA to polymers  
2. ΜΤΤ  
The cytotoxic effects of the photosensitizers studied 
decreased as follows: CQ\BP\9-F\BZ. ROS 
production was dose- and time- dependent, and 
declined in the order: BZ\9-F\ BP\ CQ. ROS induced 
by aliphatic ketones (CQ) were efficiently scavenged 
by hydroquinone and vitamin E, whereas those by 
aromatic ketones (9-F) by mannitol and catalase, 
suggesting that OH radicals were involved in ROS 
derived from 9-F.  Int. J. Mol. Sci. 2009, 10                 
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Table 1. Cont. 
Heil et al. 
2002 [108] 
HEMA (10-300 mM) 
TEGDMA (0.5-10 mM ) 
BisGMA (0.1-1 mM) 
THP-1 monocytes 
Primary peripheral blood 
monocytes (PBM) 
1.Cytotoxicity 
2. TNF-a secretion with 
LPS stimulation 
1. MTT 
2. Spectrophotometrically 
PBMs were 3-25 times less sensitive than TPH 1 
cells but the cytotoxicity ranking of the components 
was identical BisGMA > TEGDMA > HEMA) 
About et al. 
2002 [79] 
UDMA (1 μΜ)  
TEGDMA (10 μΜ) 
HEMA (10 μΜ) 
 BisGMA (1 μΜ) 
Human Pulp Fibroblasts 
(HPF) 
1.Differentiation using 
culture medium 
containing β-
glycophosphate 
1.Histochemistry (alkaline 
phosphatase) and 
Immunocytochemistry 
(anti-collagen I, anti-
dentin sialoprotein-DSP) 
All monomers significantly decreased DSP 
expression and completely inhibited the normal 
mineralization process of HPCs expressed by 
mineral nodule formation. These effects were 
observed at nontoxic concentrations and were more 
pronounced for HEMA and BisGMA. 
Janke at al. 
2003 [119] 
TEGDMA (1-7.5 mM ) 
 
Human gingival fibroblasts 
(HGFs) 
1. Cytotoxicity 
2.Apoptosis 
1. Spectrophotometrically 
(Hoechst 33342) 
2. FACs (Annexin V-PI) 
and microscopically  
TEGDMA was cytotoxic and "apoptotic" in a dose- 
and time-dependent manner. TEGDMA at 5 and 7.5 
mM inhibited proliferation and caused apoptosis, 
whereas no apoptosis or necrosis was observed with 
1 mM or 2.5 mM TEGDMA. 
Stanislawski 
et al. 2003 
[123] 
TEGDMA (0-3 mM)  Human gingival fibroblasts 
(HGFs) and Human Pulp 
Fibroblasts (HPF) 
1.Cytotoxicity 
2.GSH levers 
3.ROS generation 
 
1. MTT 
2.Spectrophotometrically 
(mBCl) 
3.Spectrophotometrically 
(DCFH-DA) 
TEGDMA-induced cytotoxicity on HGFs and HPFs 
is associated with a rapid and drastic depletion of 
GSH followed by a production of ROS. 
Antioxidants, such as NAC, ascorbate, and Trolox, 
restored GSH levels to normal and appear to have a 
crucial role in cell protection. 
Noda et al. 
2003 [141] 
HEMA (0-1.2 mM) 
TEGDMA (0—0.75 
mM) 
Human THP-1 monocytic 
cells 
1.TNF-a secretion  1.ELISA  TEGDMA and HEMA did not induce TNF-a 
secretion by themselves, but significantly suppressed 
(40-70%) LPS induced TNF-a secretion at subtoxic 
concentrations.  
Walther et al. 
2004 [125] 
HEMA (0.1-15 mM) 
TEGDMA (0.01-2 mM ) 
in the presence of several 
vitamins (A, C, E, uric 
acid) 
11Lu cells & 16Lu cells 
(human, lung, fibroblast-
like), A549 (human lung 
cell carcinoma) and L2 
cells (rat, alveolar 
epithelial) 
1.GSH content  
2.GSSG reductase activity 
3. Protein determination 
1,2 Spectrophotometrically 
(DTNB and NADPH) 
3.methionine incorporation 
Αll antioxidative substances were able to diminish 
the acute toxic effects of the monomers. 500 μmol/L 
Vitamin C or 250 μmol/L Vitamin E were mostly 
able to decrease toxicity of HEMA and TEGDMA in 
the cell lines tested. Int. J. Mol. Sci. 2009, 10                 
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Spagnuolo et 
al. 2004 
[150] 
HEMA (0–10 mM) 
 
Human skin fibroblasts 
(HSF) 
1.Apoptosis 
2.ROS generation 
3.NFkB expression 
1.FACs (Annexin V-PI) 
2. FACs (DCFH-DA) 
3. SDS-PAGE, WB & 
EMSA 
HEMA induced apoptosis in HSFs, involving 
activation of caspase-8,-9 and -3.Apoptosis was not 
directly dependent on the generation of ROS, as it 
was not reduced by antioxidants. Moreover, NF-kB 
plays a major role in protecting cells from HEMA 
induced apoptosis.  
Spagnuolo et 
al. 2004 
[120] 
TEGDMA (0-3 mM )  Human Pulp Fibroblasts 
(HPF) 
1.Apoptosis 
2. PI3K Signaling 
1.FACs (Annexin V-PI) 
2.WB 
 
Apoptotic and necrotic cell populations differentially 
increased after exposure to increasing concentrations 
of TEGDMA. A two-fold increase in the percentage 
of where apoptotic cells was induced by 1 mmol/L 
TEGDMA, as necrosis was more pronounced at 2 
mmol/L. Inhibition of the MAP Kinase/ERK 
pathway had no influence on cell survival, but 
inhibition of PI3-Kinase amplified TEGDMA-
induced apoptosis. 
Lefeuvre et 
al. 2004 
[128] 
TEGDMA (0-3mM)  Human gingival fibroblasts 
(HGFs) 
1.Cytotoxicity 
2.GSTP1(glutathione 
transferase P1) 
genotyping, GSH, GSSG 
(oxidized GSH) levels 
and GSTP1 activity  
1.MTT 
2. Spectrophotometrically 
(various assays) 
TEGDMA induces depletion of GSH and modulates 
the GSTP1 activity in both HGFs and a cell-free 
system. This is significantly more marked in the 
wild-type enzyme compared with the mutant one. 
Moreover, TEGDMA is a non-competitive 
antagonist of GSTP1. These data suggest that GSTP1 
polymorphism could be involved in inter-individual 
susceptibility to TEGDMA. 
Engelmann 
et al. 2004 
[156] 
Bis-GMA (0.001-0.25 
mM) 
Human gingival fibroblasts 
(HGFs) 
1.Cytotoxicity 
2.GSH content 
3. Cell death 
1. Spectrophotometrically 
(Hoechst 33342) 
2. Spectrophotometrically 
(MBBr assay) 
3. FACs (Annexin V/PI)  
Bis-GMA induced a rapid and intense decline of the 
glutathione pool of HGFs combined with apoptosis 
at much lower concentrations (>0,1 mM) compared 
to TEGDMA (>5 mM)  Int. J. Mol. Sci. 2009, 10                 
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Atsumi et al.  
2004 [163] 
 
 
 
CQ, 9-F +DMA 
(catalysts) 
(0.01-10 mM) 
Human Pulp Fibroblasts 
(HPF) 
1.Cytotoxicity 
2. ROS production 
3. phase-transition 
properties of 
dipalmitoylphosphatidyl 
choline (DPPC)  
1. ΜΤΤ 
2. FACs 
(CDFH-DA, DCFH-DA) 
3. differential scanning 
calorimetry  
Camphoroquinone with VL irradiation increased the 
radical production, whereas 9F+VL irradiation 
increased ROS production, as well as effecting 
changes in the DPPC phase-transition properties. 
The cytotoxicity of CQ in HPF cells was smaller 
than that of 9F. The addition of DMA to the 
photosensitizer enhanced the free-radical production 
without increasing the ROS level or the cytotoxicity.  
Lefeuvre et 
al. 2005 
[132] 
TEGDMA (0-3 mM)  Human gingival fibroblasts 
(HGFs) 
1.Cytotoxicity 
2.Oxidative stress 
3.Mitochndrial damage 
4.Lipid peroxidation 
5.Mitochondrial 
membrane potential 
(MMP) 
1.LDH determination 
2.GSH determination 
3.ATP determination 
(spectrofluorometrically) 
4. TBARS determination 
5. spectrofluorometrically 
(Rhodamine 123) 
TEGDMA induced an increase of lipid peroxidation 
associated with LDH leakage and damage at 
mitochondrial level, demonstrated by the collapse of 
MMP of HGF. The effects were reduced by CCCP, 
an uncoupler of oxidative phosphorylation on lipid 
peroxidation and LDH leakage. 
Trolox, a soluble derivative of Tocopherol, weakly 
prevents ATP but not GSH depletion and totally 
protects the cells against lipid peroxidation, MMP 
collapse and cell death. 
Paranjpe et 
al. 2005 
[151] 
HEMA (1.64–16.4 mM)  Peripheral Blood 
Mononuclear Cells 
(PBMCs) from both 
healthy and HEMA-
sensitized patients & 
murine RAW cells 
1.Apoptosis  1. FACs (Annexin V-PI) 
and TUNEL assay 
HEMA induced a dose-dependent apoptosis in 
PBMCs of both healthy and HEMA-sensitized 
patients and in the RAW cells. However, induction 
of cell death by HEMA was lower in PBMCs 
obtained from patients in comparison with healthy 
individuals. This might be an important mechanism 
for the generation and persistence of hypersensitivity 
reactions in patients. Int. J. Mol. Sci. 2009, 10                 
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Engelmann 
et al. 2005 
[129] 
TEGDMA (0.1-5 mM)  
CQ (0.1-5 mM) 
Human Pulp Fibroblasts 
(HPF) 
1.ROS detection 
2. GSH content  
1. spectrophotometrically 
 (DCFH-DA) 
2. spectrophotometrically 
(MBBr assay) 
TEGDMA significantly decreased GSH at 
concentrations between 0.5 and 5 mM but did not 
elevate ROS levels. Contrary, CQ increased ROS 
formation at concentrations > 1 mM, but had only a 
moderate effect on GSH at the highest test 
concentration. 
Noda et al. 
2005 [130] 
HEMA (0-40 mmol/L) 
TEGDMA (0-3 mmol/L) 
 BP (0-100 μmol/L) 
 CQ (0-2 mmol/L) 
Human THP-1 monocytic 
cells 
1.Cytotxicity 
2.GSH levels and GSH-
GSSG balance 
1.MTT 
2. spectrophotometrically 
(Ellman’s method) 
The results indicate that these dental resin 
compounds act at least partly via oxidative stress by 
increasing GSH levels at sublethal concentrations. 
However, the GSH-GSSG ratio was relatively 
unaffected. 
Chang et al. 
2005 [149] 
HEMA (0.01–10 mM) 
 
Human Pulp Fibroblasts 
(HPF) & human gingival 
epithelial Smulow –
Glickman (S–G) cells 
1.Cytotoxicity 
2.Cell cycle 
3. GSH depletion 
4. ROS generation 
1. MTT 
2.FACs (PI) 
3. FACs (CMF-DA) 
4. FACs (DCFH-DA) 
HEMA produced growth inhibition of HPF and S–G 
cells in a dose-dependent manner, accompanied by 
induction of GSH depletion, ROS production, cell 
cycle perturbation and apoptosis.  
Schweikl et 
al. 2005 
[140] 
TEGDMA (0-3 mM)  
 
V79 Chinese hamster lung 
fibroblasts (p53 deficient) 
N1 human skin fibroblasts 
(p53 proficient) Human 
Pulp Fibroblasts (HPF) 
(p53 proficient) 
1.Cell viability 
2.Cell cycle 
1.Hemocytometer 
2. FACs (PI) 
TEGDMA caused different patterns of cell cycle 
delays in the three tested cell lines which were 
mediated both through p53-dependent (N1 
fibroblasts and primary human pulp cells) and p53-
independent (V79 cells) pathways. 
Pagoria et al. 
2005 [168] 
CQ/DMT (1-2 mM) 
 
3T3-Swiss albino murine 
fibroblasts (3T3) and 
Immortalized Murine 
cementoblasts (OCCM.30) 
1.Oxidative stress after 
visble light irradiation of 
the CQ/DMT complex 
1. spectrophotometrically 
(DCFH-DA) 
VL-irradiated CQ/DMT produced significantly 
elevated intracellular oxidative levels in both cell 
types. OCCM.30 cells were found to bet twice as 
sensitive to VL-irradiated CQ/DMT compared to 
3T3 cells. Furthermore, 10mM NAC and 10mM 
ascorbic acid were able to eliminate the oxidative 
stress.  
Cimpan et al. 
2005 [169] 
DMABEE (0-200 μΜ) 
 
U-937 monocytes  1.Cell death  1. FACs (Annexin V-PI) 
 
DMABEE caused time- and concentration- 
dependent induction of cell death in the form of 
apoptosis and necrosis. Int. J. Mol. Sci. 2009, 10                 
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Spagnuolo et 
al. 2006 
[126] 
HEMA (0–12 mM) 
in the presence of the 
antioxidant NAC (1, 5, 
and 10 mM) 
Human primary gingival 
fibroblasts (HGF) 
1.Cytotoxicity 
2. Cell Viability 
3. ROS generation 
1. MTT 
2.FACs (Annexin V-PI) 
3. FACs (DCFH-DA) 
 
HEMA at concentration >10mM caused a decrease 
of cell viability, mitochondrial activity, and an 
increase of cell death. High NAC conc. (5, 10 mM) 
protect HGF against HEMA cytotoxicity by reducing 
the induced ROS levels. 
Volk et al. 
2006 [131] 
HEMA (0.1-10 mM) 
TEGDMA (0.05-2.5 
mM) 
UDMA (0.005-0.5 mM) 
Human gingival fibroblasts 
(HGFs) 
1. GSH content  1.spectrophotometrically 
(MBBr assay) 
 
GSH depletion was dependent on the type of the 
resin monomer: UDMA > TEGDMA > HEMA. 
 
Becher et al. 
2006 [110] 
HEMA (10-2,000 
μgr/mL) 
TEGDMA (10-2,000 
μgr/m;)  
GDMA (50-100 μgr/mL) 
 
Primary alveolar mouse 
macrophages J774A1 
mouse macrophages 
1.Cytotoxicity 
2. Apoptosis 
1. MTT 
2. FACs (Hoechst 33342) 
& Fluorescent microscopy 
(Hoechst 33342/PI)  
The monomers’ cytotoxicity decreased as follows 
GDMA > TEGDMA > HEMA. The latter caused a 
greater accumulation of apoptotic cells 
Reichl et al. 
2006 [152] 
HEMA (0.1–30 mM), 
TEGDMA (0.03–10 
mM), BisGMA (0.01–0.3 
mM), UDMA (0.01–1 
mM) 
Human gingival fibroblasts 
(HGFs) 
1.Cytotoxicity 
2.Cell death 
1.XTT 
2.Hoechst 33342 staining 
The cytotoxicity of the monomers increased as 
follows: HEMA < TEGDMA < UDMA < BisGMA. 
TEGDMA induced mainly apoptosis, whereas 
HEMA, UDMA & BisGMA mainly necrosis. 
Mantellini  et 
al.  2006 
[154] 
HEMA, adhesives  Murine MDPC-23 
odontoblasts, un-
differentiated pulp cells 
(OD-21), HGFs and 
murine macrophages (Raw 
264.7) 
1.Cytotoxicity  
2. VEGF expression 
1. Τrypan Blue 
B. ELISA 
ΗΕΜΑ induced increased expression of VEGF only 
in MDPC-23 and Raw 264.7 cells. It seems that 
VEGF is implicated in angiogenesis in sites of pulp 
exposure that come in contact with dental adhesives. 
 
Falconi et al. 
2007 [117] 
HEMA (1-10 mM)  Human gingival fibroblasts 
(HGFs) 
1. Cell viability 
2. Cell morphology,  
3. Collagen I  
1. MTT 
2. SEM 
3. Immunofluorescence 
3 mmol/L HEMA did not induce cell death but 
caused a modification in the morphology of HGFs 
and a decrease in the type I collagen expression. Int. J. Mol. Sci. 2009, 10                 
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Moharamzad
eh et al. 2007 
[112] 
BisGMA (0.02-10 mΜ) 
UDMA (0.02-10 mΜ) 
TEGDMA (0.02-10 mΜ) 
Human gingival 
fibroblasts (HGFs) and 
HaCaT keratinocytes 
1.Cytotoxicity 
2.Inflammatory marker  
(IL-1β) 
1. Alamar Blue assay 
2. ELISA 
Monomers were toxic to HGFs and HaCaT. Τhe 
cytotoxicity ranking was BisGMA > UDMA > 
TEGDMA. However, they cannot induce IL-1β 
release from these cells by themselves. 
Samuelsen et 
al. 2007 
[121] 
HEMA (0-15 mM) 
TEGDMA (0-3 mM)  
Rat submandibular 
salivary gland acinar 
cells, SM 10–12 
1.ROS generation 
2.Cell death 
3.Protein analysis of p-
ERK p-JNK and p-p38 
1. spectrophotometrically 
(DCFH-DA) 
2. Hoechst 33342 staining 
3.WB 
HEMA or TEGDMA exposure resulted in ROS 
formation, concentration-dependent apoptosis and 
phosphorylation of ERK. Phosphorylation of JNK 
and p38 was induced by HEMA. Therefore, 
differential MAP kinase activation appears to be 
involved in HEMA and TEGDMA induced 
apoptosis. 
Volk et al. 
2007 [200] 
TEGDMA (0-5 mM)  Human gingival 
fibroblasts (HGFs) 
1. GSH content   1.spectrophotometrically 
(MBBr assay) 
TEGDMA induced an early and drastic depletion of 
GSH that was more pronounced in the presence of 
Η2Ο2. 
Spagnuolo et 
al. 2008 
[199] 
HEMA (1-14 mM)  Human Pulp Fibroblasts 
(HPF) 
1.Cell viability 
2. ROS generation 
3.Expression of P-Akt and 
P-ERK1/2 
1. FACs (Annexin V-PI) 
2. FACs (DCFH-DA) 
3.WB 
 
HEMA exposure modulated ERK and Akt pathways 
in different manners and these in turn function in 
parallel to mediate pro-survival signaling in HPF 
subjected to HEMA cytotoxicity. 
Teti et al. 
2008 [148] 
HEMA (3 mM)  Human gingival 
fibroblasts (HGFs) 
1.Cytotoxicity 
2. Expression of pro-
collagen a1.  
1. MTT 
 2. Real Time RCR, WB 
and Immunofluorescence 
Exposure of HGFs in 3 mM HEMA interferes both 
with the synthesis of the procollagen a1 type I 
protein and its mRNA expression, suggesting that 
normal cell production and activity are modified by 
HEMA at concentrations below those which cause 
acute cytotoxicity. 
Reichl et al. 
2008 [111] 
HEMA (0.1–30 mM) 
TEGDMA (0.03–10 mM) 
; BisGMA (0.01–0.3 mM); 
UDMA (0.01–1 mM) 
Human gingival 
fibroblasts (HGFs) and 
Human Pulp Fibroblasts 
(HPF) 
1.GSH content  
 
1,2 Spectrophotometrically 
(DTNB and NADPH) 
3.methionine incorporation 
The addition of H2O2 (0.06 or 0.1 mmol/L) resulted 
in a toxicity potentiation of TEGDMA and UDMA, 
but not of HEMA and BisGMA, on HGF or HPF. Int. J. Mol. Sci. 2009, 10                 
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Emmler et al. 
2008 [118] 
TEGDMA (0.003–10 
mM) TEG +MA 
(equimolar TEGDMA) 
(0.03–10 mM), TEG 
(0.03–10 mM) MA 
(0.03–30 mM) 
2,3-EMA (0.001–30 
mM) and PFA (0.03–10 
mM). 
Human bronchoalveolar 
carcinoma-derived A549 
cells 
1.Cytotoxicity 
 
1.XTT  The epoxy compound 2,3-EMA induced comparable 
toxic effects as the raw TEGDMA. On the contrary, 
no cytotoxic effects could be found for TEG up to a 
concentration of 10mM. It was concluded that some 
toxic intermediates might significantly contribute to 
TEGDMA-induced cytotoxicity.  
Schweikl et 
al. 2008 
[124] 
TEGDMA (1 mM and 3 
mM) 
Normal human skin 
fibroblasts (N1) 
1. ROS generation 
2. Cell cycle analysis 
3 Gene expression 
analysis 
 
1.FACs (DCFH-DA) 
2. FACs (PI) 
TEGDMA at 3 mM increased ROS production and 
caused a cell cycle delay after 6 hours. The 
predominant biological processes associated with the 
genes that were differentially expressed included 
oxidative stress, cellular growth, proliferation and 
morphology, cell death, DNA replication and repair. 
The most upregulated genes were GEM (17-fold), 
KLHL24, DDIT4, TGIF, DUSP5 and ATF3, which 
are related to the regulation of the cell structure, 
stress response and cell proliferation. TXNIP was the 
most downregulated transcript, which regulates the 
cellular redox balance.  
Gregson et 
al. 2008 
[144] 
TEGDMA (1.25 and 1.5 
mM) 
Monocyte derived 
macrophage (U937) cells 
Human gingival fibroblasts 
Human Pulp Fibroblasts 
1.Cytokine/growth factor 
secretion 
2.Hydrolase activity  
1. Human cytokine 
antibody detection kit 
2. spectrophotometrically 
(p-nitrophenyl butyrate) 
TEGDMA induced the secretion of the cytokine 
MCP-1 from U937 cells and also increased the 
hydrolase activity in the HGF. These results showed 
that TEGDMA induces enzymatic activity and 
cytokine/growth factor expression in a cell-specific 
manner. Int. J. Mol. Sci. 2009, 10                 
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Eckhardt et 
al. 2009 
[122] 
TEGDMA (0-2 mM)  Murine RAW264.7 
macrophages 
1.Cell survival 
2.Cytokine release (TNF-
a, IL-6, IL-10) 
3.Expression of cell 
surface antigens (CD14, 
CD40, CD80, CD86, 
CD54, MHC class I, II) 
1.Crystal violet staining 
2.ELISA 
3.FACs 
TEGDMA resulted in inhibition of LPS-induced 
release of TNF-a, IL-6, and IL-10 by 90%. The 
expression of CD14 was inhibited by high 
TEGDMA concentrations. CD40, CD80, CD86 and 
MHC class I were also down-regulated. On the 
contrary, CD54 was increased about twofold by 
increasing TEGDMA concentrations. Thus, the 
ability of macrophages to induce an appropriate 
immune response is inhibited by TEGDMA. 
Lee et al. 
2009 [145] 
HEMA (0-12 mM) 
TEGDMA (0-3 mM)  
 
Murine RAW264.7 
macrophages 
1.Cell viability 
2. COX-2 and iNOS gene 
expression  
3. COX-2 protein 
expression 
1.WST-8 assay 
2.RT-PCR 
3.WB 
It was found that COX-2 expression was stimulated 
by TEGDMA and HEMA. PGE2 was produced by 
TEGDMA but not by HEMA in the murine cell line. 
These findings suggest that TEGDMA and HEMA 
can be a critical factor of inflammation related to 
resin-based dental biomaterials. 
Imazato et al. 
2009 [160] 
TEGDMA (100–10 
μg/mL), MMA (10–1 
μg/mL)  
HEMA (400–50 μg/mL)  
Οsteoblast-like MC3T3-E1 
cells 
1.Cytotoxicity 
2. Cell morphology 
3.ALP Activity 
4 Differentiation 
5.Mineralized Tissue 
1.MTT 
2.SEM 
3. Spectrophotometrically 
4.RT-PCR 
5.Alisarin Red staining 
TEGDMA and MMA did not affect the growth of 
MC3T3-E1 and exhibited little harmful effects on 
their differentiation and mineralization. On the 
contrary, HEMA inhibited proliferation, ALP 
activities, the expression of osteocalcin, and 
mineralized tissue formation at 200 μg/mL or more. 
Chang et al. 
2009 [155] 
BisGMA (0.025-0.2 
mM) 
Human Pulp Fibroblasts 
(HPFs) 
1.Cytotoxicity 
with/without aspirin, 
catalase, and U0126 
2. PGE2 production 
3.COX-2 mRNA & 
protein expression and 
ERK1/2 phosphorylation 
4.ROS production 
1.MTT 
2.ELISA 
3.RT-PCR, WB 
4. FACs (DCFH-DA) 
BisGMA (>0.075 mM) induced cytotoxicity to 
HPFs. BisGMA (0.1 mM) also stimulated ERK 
phosphorylation, PGE2 production, COX-2 mRNA 
and protein expression, as well as ROS production. 
Catalase and U0126 (a MEK inhibitor) effectively 
prevented these phenomena Moreover, catalase can 
protect the pulp cells from BisGMA cytotoxicity, 
whereas aspirin and U0126 lacked of this protective 
activity. 
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Study Substances  studied 
(concentration) 
Cell line  Biological parameters 
assessed 
Methods Main  conclusions 
Schweikl et al. 
1999 [138] 
TEGDMA  V79 Chinese hamster 
lung fibroblasts  
Α. Genotoxicity 
Β. hprt expression 
1. Micronucleus test  
2.PCR  
ΤEGDMA induced dose-dependent increase of micronuclei  
and hprt deletions in a total of 24 cell clones. 
Li et al. 1999  
[139] 
HEMA Human  Pulp 
Fibroblasts (HPF) 
1.cytotoxicity 
2.Cell cycle 
1. MTT  
2. FACs (PI) 
HEMA induced dose dependent cytotoxicity and cell cycle 
arrest in G2 phase. 
Schweikl et al. 
2001 [104] 
BisGMA (0-0.075 
mΜ) 
UDMA (0-0.075 
mΜ) 
HEMA (0-5 mM) 
TEGDMA (0-1 mM)  
GMA (0-0.2 mM) 
MMA (0-30 mM) 
BPA (0-0.2 mM) 
V79 Chinese hamster 
lung fibroblasts 
1.Cytotoxicity  
2.Genotoxicity 
1. Crystal Violet staining 
2.Micronucelus test in vitro 
(in presence or absence of 
mix) 
The cytotoxicity ranking was BisGMA > UDMA > BPA > 
GMA >>> TEGDMA >>> HEMA > MMA. A dose-related 
increase of micronuclei was observed by TEGDMA, HEMA 
and GMA. These effects were reduced by S9 mix. 
Kostoryz et al. 
2003 [158] 
Bis-GMA, BFDGE 
& metabolites (0.001-
10 mM) 
L-929 mouse 
fibroblasts 
MCF- 7 human breast 
cancer cells  
1.cytotoxicity 
2.mutagenesis 
3.estrogenic effects 
1. ΜΤΤ 
2. Ames test 
3.Cell proliferation 
Hydroxylized metabolites of Bis-GMA & BFDGE were less 
cytotoxic than initial monomers and presented no mutagenic 
or estrogenic effects. 
Kleinsasser et al. 
2004 [137] 
UDMA , TEGDMA 
HEMA, BisGMA 
(10
-8 10
-7, 10
-6 10
-5, 
10
-4 10
-3 10
-2 and 
2.5x10
-2 M) 
Human peripheral 
lymphocytes 
1.Cytotoxicity 
2.Genotoxicity 
1. Trypan Blue 
2. Single gel electrophoresis 
(Comet) assay  
At higher concentrations, the monomers tested induced 
significant but mild enhancement of DNA migration in the 
Comet assay, as a possible sign for limited genotoxic effects. Int. J. Mol. Sci. 2009, 10                 
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Lee et al. 2006  
[109] 
HEMA (1-18 mM) 
TEGDMA (0.4-5 
mM)  
GMA (0.08-0.8mM) 
in presence of NAC  
V79 Chinese hamster 
lung fibroblasts  
RPC-C2 Rat clonal 
dental pulp cells 
1.Cytotoxicity 
2.Genotoxicity 
3.Apoptosis 
1. MTT 
2.Micronucleus test & DNA 
gel electrophoresis 
3.Flow cytometry (Annexin 
V-PI) 
All monomers exhibited dose-dependent cytotoxic and 
genotoxic effects, with the following ranking GMA > 
TEGDMA > HEMA. These effects were significantly 
reduced in the presence of NAC.  
 (10  mM)         
Kleinsasser et al. 
2006 [136] 
UDMA , HEMA, 
TEGDMA (10
-7, 10
-5, 
10
-3, and 2.5x10
-2 M) 
Human samples of 
salivary glands and 
peripheral 
lymphocytes 
1.Cytotoxicity 
2.Genotoxicity 
1. Trypan Blue 
2. Single gel electrophoresis 
(Comet) assay  
The monomers tested induced significant DNA migration in 
both cell types detected in the Comet assay even at non toxic 
concentrations. These genotoxic effects suggest a tumor 
initiating potency of the tested dental materials 
Schweikl et al. 
2007 [127] 
HEMA (2-8 mM) 
TEGDMA (0.5-3 
mM) in the presence 
of NAC (1, 5, 10 
mM) 
V79 Chinese hamster 
lung fibroblasts 
1.Cell cycle 
2.Genotoxicity 
1.FACs (PI) 
2. Micronucleus test in vitro 
V79 cells were protected from genotoxicity and disruption of 
the cell cycle by TEGDMA and HEMA in the presence of 
high NAC concentrations (5, 10 mM).  
Li et al. 2007  
[165] 
CQ ± DMT ±  
VL irradiation 
Chinese hamster 
Ovary (CHO) cells 
1.Genotoxicity 
2.Cell cycle 
1.Micronucleus tests 
2. CBPI =Cytokinesis Block 
Proliferation Index  
CQ/DMT with or without VL irradiation caused significant 
prolongation of the cell cycle. In addition, VL irradiated 
CQ/DMT was found to exhibit significantly genotoxic and 
cytotoxic effects, compared with CQ/DMT alone. These 
effects were reduced by pre-treatment with antioxidants. 
Eckhardt et al. 
2009 [143] 
TEGDMA (0-5 mM)  THP-1 monocytes  1.Cell viability 
2. DNA damage 
3. Cell cycle 
4. Detection of pATM, 
phospho-p38 and phospho-
ERK1/2 
1.MTT 
2. Detection of 8-oxoguanine 
(OxyDNA Assay) 
3. FACs (PI) 
4. FACs analysis (antibodies) 
TEGDMA induced oxidative DNA damage followed by 
activation of ATM and various signal transduction pathways 
through MAP kinases which also regulate cell death and 
survival.  
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4.2.1. TEGDMA (Triethyleneglycol Dimethacrylate)  
 
TEGDMA has been the most extensively studied resinous monomer with respect to 
biocompatibility, since it is easily released from polymerized composites into aqueous media and 
accounts for most of the unreacted double bonds [23,42]. Moreover, TEGDMA is a commonly used 
diluent of many resin-based dental composites and also a common component of dentin adhesives in 
contents varying from 25 to 50% [2,6]. Due to its lipophilic nature, TEGDMA can easily penetrate the 
cytosol and membrane lipid compartments of mammalian cells [115].  
TEGDMA has been reported to induce time- and concentration- dependent cytotoxicity in various 
cell lines, as shown in Table 1. In most studies, TEGDMA concentration ranged from 0.5-5 mM. 
Moreover, its lethal concentrations have been reported to vary in different cell lines and among the 
same types of cells obtained from different donors [116,117]. It is also to note that some of the 
metabolic products of TEGDMA, such as the epoxy compound 2,3-epoxymethacrylic acid (2,3-EMA) 
have been found to cause comparable cytotoxic effects, contributing to TEGMA cytotoxicity. On the 
other hand, other metabolites, such as triethylene glycol (TEG and methacrylic acid (MAA) have 
shown minimal cytotoxicity [118]. At lower concentrations the predominant type of cell death induced 
by TEGDMA was apoptosis (programmed cell death), whereas necrosis was more pronounced at 
higher concentrations [109,119-121]. TEGDMA–induced apoptosis was enhanced by its inhibitory 
effect on phosphatidylinositol 3-kinase in primary human pulp cells [116] and by differential 
activation of MAP-kinase signaling pathways [121,122]. There is evidence that the balance between 
the sustained activation of the MAP kinases ERK1/2 and the stress kinases p38 and JNK is most likely 
a central factor in the regulation of cell death and survival in TEGDMA-treated cell   
cultures [122]. 
TEGDMA-induced apoptosis was also found in a number of studies to be associated with oxidative 
stress via Reactive Oxygen Species (ROS) generation [121,123,124]. This was further supported by 
the fact that its cytotoxicity was reduced in the presence of antioxidants, such as N-acetylcysteine 
(NAC), ascorbate, vitamins A and E (Trolox), uric acid etc [123,125-127]. ROS generation was 
accompanied in various cell lines by depletion of intacellular glutathione (GSH), a major natural 
reducing agent implicated in cellular detoxification and maintenance of redox balance. [128-131]. 
Lefeuvre  et al. [128] also found significant reduction of glutathione transferase P1 activity by 
TEGDMA in human gingival fibroblasts. They supported that TEGDMA is a non-competitive 
antagonist of GSTP1 and that GSTP1 polymorphism could be involved in inter-individual 
susceptibility to TEGDMA cytotoxicity. The same authors supported that GSH depletion was 
accompanied by lipid peroxidation and mitochondrial damage, indicated by a collapse of the 
mitochondrial membrane potential [132]. These effects were significantly reduced by a soluble 
derivative of tocoferol (vitamin E) and by CCCP (carbonylcyanide m-chlorophenylhydrazone), an 
uncoupler of oxidative phosphorylation on lipid peroxidation and LDH leakage. 
Several studies have supported that the cell death pattern could be important regarding the 
evaluation of the potential of dental materials to cause adverse effects [110,120,133], as apoptotic cells 
are removed by phagocytosis and with little inflammatory response. The latter is in sharp contrast to 
the inflammation and injury to surrounding tissues induced by the necrotic process [134,135]. Int. J. Mol. Sci. 2009, 10                 
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TEGDMA has been also reported to induce significant genotoxic damage at subtoxic 
concentrations. It has been found to increase the number of micronuclei [104,109] and promote 
degradation of DNA derived from salivary gland tissue and lymphocytes, as shown in comet assays 
[136,137]. The induction of micronuclei was however clearly abolished by a microsomal fraction (S9) 
from rat liver, which indicates that the metabolites of TEGDMA are not able to cause genotoxic 
damage. Antioxidants were also able to reduce TEGDMA induction of micronuclei [123]. TEGDMA 
was also reported to induce extensive deletions of nucleotide sequences in the hypoxanthine-guanidine 
phosphoribosyltransferase (hprt) gene in V79 Chinese hamster lung fibroblasts, which is indicative of 
the clastogenic potential of this chemical [138]. Most recently, it has been reported that TEGDMA is 
able to cause oxidative DNA damage, indicated by the generation of 8-oxoG, followed by activation of 
ATM, which by itself might activate pathways leading to apoptosis [122]. Moreover, Schweikl et al. 
[124] have shown using microarrays technology that TEGDMA-induced cell damage is followed by a 
coordinated induction of genes coding for significant biological processes, including oxidative stress, 
cellular growth, proliferation and morphology, cell death, DNA replication and repair. The most 
upregulated genes were GEM, KLHL24, DDIT4, TGIF, DUSP5 and ATF3, which are related to the 
regulation of the cell structure, stress response and cell proliferation, whereas the most down-regulated 
transcript was TXNIP which regulates the cellular redox balance. As a consequence of DNA damage, 
different patterns of cell cycle delays-mainly in G2 phase- have been reported for different cell lines 
exposed to TEGDMA, in order to allow DNA repair processes [139,140]. These delays have been 
shown to be mediated through both p53-dependent and p53-independent pathways, in different cell 
lines [140]. 
Of major clinical significance are the long term effects of TEGDMA at subtoxic concentrations. It 
has been reported that TEGDMA cannot induce TNF-a release from THP-1 monocytes by itself, but it 
suppresses LPS-induced TNF-a secretion, suggesting some modification of the normal inflammatory 
response of pulpal tissues [141]. Moreover, other inflammatory mediators, such as IL-6 and IL-8 are 
released from 3-D cultures of TR146 cells exposed to TEGDMA [142]. Most recently, it has been 
shown that TEGDMA modulates LPS-induced production of not only TNF-a, but also of many other 
cytokines. It has been found to suppress IL-6 and IL-10 production by about 90% and CD14 
expression at high concentrations. Moreover, CD40 and CD80 were down-regulated, whereas CD86 
and MHC class I were inhibited to a lesser extent. On the contrary, CD54 was increased about twofold 
by increasing TEGDMA concentrations [143]. TEGDMA has been also found to induce cytokine 
MCP-1 secretion from U937 cells and to increase the hydrolase activity in human gingival fibroblasts 
[144]. Other inflammation markers, including Prostaglandin E2 were found to be increased in murine 
macrophages [142]. Overall, these data suggest that TEGDMA has a strong influence on the 
interaction of immune cells, including presentation of antigens, co-stimulation of T-cells, and cell–cell 
interactions [145].  
Long term exposure to subtoxic concentrations of TEGDMA is not only able to affect immune 
responses but also other physiological processes, such as wound healing, cell differentiation and 
cellular metabolism. It has been found that TEGDMA is able to affect the physiological differentiation 
processes of dental pulp fibroblasts into odontoblasts and their normal mineralization procedure at 
very low concentrations [79]. TEGDMA has been found to modulate stress response by suppressing 
the expression of heat shock proteins, such as HSP72 [62]. Moreover, in a very interesting study by Int. J. Mol. Sci. 2009, 10                 
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Engelmann  et al. [146] TEGDMA was detected by NMR spectroscopy in all cellular fractions 
(cytosol, lipid fractions, as well as the culture media) and was able to affect the metabolic state of the 
cells by increasing the ratio of nucleoside diphosphates to nucleoside triphosphates. 
Therefore, it can be concluded from the above presented studies that TEGDMA is a very active 
methacrylate molecule, that is able to cause not only pronounced cytotoxic and genotoxic effects 
mainly through oxidative stress pathways in different cell types but also to influence significant 
cellular functions implicated in immune response, wound healing and cellular metabolism even at very 
low (subtoxic) concentrations.  
 
4.2.2. HEMA (2-Hydroxy-ethyl-methacrylate) 
 
HEMA has been also widely studied for biocompatibility, as it is one of the most common 
components of dentin-adhesives, ranging from 30 to 55% and has a pivotal role during the dentin 
impregnation process of adhesive systems. This is due to its high water affinity, which allows HEMA 
to flow into the collagen network of the dentin organic matrix, thus favoring infiltration and preventing 
collagen collapse [147]. Because HEMA has a low molecular weight and high hydrophilicity, it can 
also diffuse throughout the residual dentin and affect the underlying odontoblast vitality, altering cell 
division and physiological activity [61,148]. According to Spagnuolo et al. [126] the release of HEMA 
from polymerized dental adhesives ranges from 1.5 mmol/L to 8 mmol/L. 
In terms of cytotoxicity, HEMA has been found to be far less toxic, as compared to the bifunctional 
monomers [102,104,106-111,116]. However, the TC50 concentration varied significantly with 
different cell lines and among the same types of cells obtained from different donors, ranging from 
3.6 mmol/L to 10 mmol/L in various studies [63,112,117,126]. According to most of these studies the 
cytotoxicity of HEMA was time-and concentration-dependent. 
HEMA induced cytotoxicity was also associated with oxidative stress, indicated by ROS production 
and depletion of intracellular glutathione [111,130,131,149]. These effects were found to be reduced in 
the presence of antioxidants [109,125,126]. Chang et al. [149] however reported that ROS production 
induced by HEMA is probably not followed by GSH depletion in human gingival epithelial cells, 
because GSH depletion was marked only at high concentrations, while an excessive ROS production 
was noted also at lower concentrations. Likewise, a significant change of the GSH-GSSG ratio was not 
assessed in THP-1 human monocytic cells after treatment with HEMA sub-lethal concentrations [130]. 
The resulting imbalanced redox state caused by HEMA is further associated with cell cycle delays 
and apoptosis involving activation of caspases-8,-9 and -3 [139,149,150]. HEMA induced apoptosis 
was found to be associated with the activation of nuclear factor kappa B (NF-kB), which plays a 
protective role to counteract HEMA cytotoxicity [150] and differential MAP kinase activation, 
including phosphorylation of JNK and p38 [121]. HEMA induced apoptosis has been also proposed as 
an important mechanism for the generation and persistence of hypersensitivity reactions of patients to 
this monomer. Paranjpe et al. [151] have shown that HEMA induced a dose-dependent apoptosis in 
Peripheral Blood Mononuclear Cells (PBMCs) of both healthy and HEMA-sensitized patients. 
However, induction of cell death by HEMA was lower in PBMCs obtained from patients in 
comparison to healthy individuals. On the contrary, other studies with primary human gingival Int. J. Mol. Sci. 2009, 10                 
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fibroblasts cultures have supported that HEMA induced cell death is mainly in the form of necrosis 
rather than apoptosis [126,152]. 
In terms of genotoxicity, HEMA has been also reported to be a clastogenic chemical by increasing 
the number of micronuclei, effects that were however diminished after metabolic inactivation 
[104,109]. It has been also found to increase DNA migration in Comet assays [136,137]. These effects 
were followed by cell cycle delays, but were found to be reduced in the presence of antioxidants [127]. 
Several studies have also evaluated the effects of HEMA at very low concentrations in long-term 
cytotoxicity systems that are more relevant to clinical conditions. HEMA has been found to alter the 
normal inflammatory response of pulpal tissues, by significantly reducing TNF-a secretion from   
LPS-stimulated human THP-1 monocytes and peripheral blood monocytes [108,141,145,153]. These 
findings are further supported by the fact that HEMA was found to induce up-regulation of COX-2 
[145] and VEGF expression [154], as well as suppression of Hsp72 expression in immune cells [62], 
suggesting its implication in inflammation related processes caused by composite materials. Other long 
term effects of HEMA include the interruption of normal collagen I synthesis [117,148] and the 
significant perturbation of normal differentiation processes of pulp fibroblasts into odontoblasts [79], 
which has a critical significance in pulpal homeostasis and repair.  
In conclusion, HEMA was also found to be a very active biologic molecule, although its 
cytotoxicity is much lower compared to the bifunctional monomers TEGDMA and BisGMA. 
However, its pivotal role during composites adhesion into dentin and its high mobility due to its 
hydrophilicity and low molecular weight make it a critical molecule from the viewpoint of 
biocompatibility. The mechanisms of its cytotoxic and genotoxic effects seem not to differ from those 
of TEGDMA and mainly involve oxidative stress via ROS production. Of significant importance are 
also the long term effects of HEMA at subtoxic concentrations, which are able to disturb physiological 
pulp homeostasis and repair.  
 
4.2.3. Basic Monomers BisGMA (2,2-Bis[4-(2- hydroxy-3-methacryloxypropoxy) phenyl]propane) 
and UDMA (Urethane dimethacrylate) 
 
The basic bifunctional resinous monomers BisGMA (2,2-bis[4-(2-hydroxy-3-methacryl-
oxypropoxy)phenyl]propane) and UDMA (urethane dimethacrylate) have been also studied for 
cytotoxicity and genotoxicity in a considerable number of studies. In general, the aromatic monomer 
BisGMA has been found to be slightly more cytotoxic than the aliphatic monomer UDMA 
[102,104,106-110,112,116,152]. Despite the fact that BisGMA is not readily soluble in water and 
available only in small amounts in a hydrophilic environment it has been used as a representative 
acrylate compound for studying the toxic mechanisms of resin monomers on biological tissues 
[155,156]. On the other hand, UDMA, that has been often used today to replace BisGMA in many 
commercially available dental composites due to its high flexibility and toughness, represents a family 
of molecules with different molecular weight and structure that have been relatively less studied 
compared to other methacrylate molecules [157]. 
BisGMA (>0.001 mM) and UDMA (0,05 mM) have been found to cause time- and concentration-
dependent cytotoxicity to various cell lines, including human gingival and pulp fibroblasts and human 
THP-1 and peripheral blood monocytes [108,131,153,156,158,159]. Bis-GMA have been also found to Int. J. Mol. Sci. 2009, 10                 
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induce a rapid and intense decline of the glutathione pool of HGFs combined with induction of 
apoptosis at much lower concentrations (>0.1 mM) as compared to TEGDMA (>5 mM) [156]. 
BisGMA could also stimulate ERK phosphorylation, PGE2 production, COX-2 mRNA and protein 
expression, as well as ROS production. Catalase and U0126 (a MEK inhibitor) were able to effectively 
prevent the above mentioned effects [155]. These findings suggest that BisGMA released from 
composite resins may potentially affect the vitality of dental pulp and/or induce pulpal inflammation. 
This is further supported by the fact that BisGMA is able to disturb normal differentiation procedures 
of pulp fibroblasts [79,160]. Other long term effects of BisGMA include its ability to affect the 
migration and tenascin expression of keratinocytes and human gingival fibroblasts, possibly disturbing 
the healing of injured oral tissues [161]. Moreover, BisGMA and its biodegradation product 
methacrylic acid (MMA) have been found to significantly decrease ICAM-1 expression in   
TNF-a-stimulated cells, which suggests that these methacrylates may decrease the recruitment of 
leukocytes towards the inflammation sites [158]. 
Concerning genotoxicity, BisGMA and UDMA has been also found to increase the number of 
micronuclei and these effects to be reduced by S9 mix, in the same way as with TEGDMA and HEMA 
[104]. DNA migration has been also reported in Comet assays for these monomers [136,137]. On the 
other hand, the hydroxylized metabolites of Bis-GMA, such as Bisphenol A bis (2,3-dihydroxypropyl) 
were found to be non-mutagenic and less cytotoxic than their parent monomer [159]. 
In conclusion, the basic resinous monomers BisGMA and UDMA, which account for about 70-75% 
of the total resinous matrix of dental composites may significantly contribute to these materials 
cytotoxicity and genotoxicity. Despite their hydrophobic character which limits their release into 
aqueous environments they are able to exert their cytotoxic action at much lower concentrations as 
compared to HEMA and TEGDMA. Involved mechanisms seem also to include oxidative stress, as 
well as disturbance of normal biological processes, such as differentiation, immune response and 
wound healing at very low concentrations.  
 
4.3. Compounds of Dental Composites’ Polymerization System 
 
Extractable components of resin-based dental restorative materials also include substances of their 
polymerization system, such as photosensitizers and initiators [16]. Camphoroquinone (CQ) is the most 
commonly used photosensitizer and has been found to be eluted by various resin composites. Very few 
studies up to now have addressed the potential biological adverse effects of CQ. It has been shown that 
CQ in the presence or absence of reducing agents was cytotoxic to a human submandibular duct cell 
line, as well as to human gingival and pulp fibroblasts [162,163]. In addition, many of the most known 
polymerization initiators, such as CQ, benzoyl peroxide (BPO) dimethylaminoethyl methacrylate 
(DMAEMA) and dimethyl-para-tolouidine (DMPT) have been found to be cytotoxic to human 
gingival fibroblasts by inducing cell cycle arrest and cell death mainly in the form of necrosis [164]. 
When compared to other photosensitizers, such as benzil (BZ), benzophenone (BP),   
9-fluorenone (9-F), CQ was found to be less cytotoxic and to produce less ROS. Moreover, ROS 
induced by the aliphatic ketone CQ were efficiently scavenged by hydroquinone and vitamin E, 
whereas those by the aromatic ketone 9-F were diminished by mannitol and catalase, suggesting that 
OH radicals were involved in ROS derived from 9-F [162]. In addition, CQ in combination with Int. J. Mol. Sci. 2009, 10                 
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visible light (VL) irradiation was found to increase the radical production, whereas 9F with VL 
irradiation increased ROS production and effecting changes in the phase-transition properties of DPPC 
liposomes, which were used as a model for cell membranes. The addition of DMA (a tertiary amine) to 
the photosensitizer enhanced the free-radical production without increasing the ROS level or the 
cytotoxicity. The authors concluded that CQ/DMA is a valuable combination for the polymerization of 
dental resins because of its less photo-oxygenation and cytotoxicity together with its great ability to 
cause polymerization of methacrylates. On the other hand, another scientific group has shown that 
CQ/DMT with or without VL irradiation was able to cause significant prolongation of the cell cycle. In 
addition, VL irradiated CQ/DMT was found to exhibit significantly genotoxic and cytotoxic effects, 
compared with CQ/DMT alone. These effects were however reduced by pre-treatment with 
antioxidants [165]. These results are in agreement with Pagoria et al. [166] who reported that VL 
irradiated CQ/DMT caused DNA strand breakages in isolated supercoiled plasmid DNA, and Winter  
et al. [167], who demonstrated that VL irradiated CQ/ DMT caused DNA damage in a cell-free 
environment. Moreover, recently, Pagoria and Geurtsen [168] have published that VL irradiated 
CQ/DMT caused oxidative damage in 3T3-Swiss albino murine fibroblasts and murine cementoblasts. 
They also confirmed the protective effect of high concentrations of NAC (10 mM) and ascorbic acid 
(10mM) in these cell lines. Taken together, these results suggest that the CQ/DMT system can act as a 
genotoxic agent. 
Other substances of the polymerization system of dental composites have been also studied to a 
lesser extent for biocompatibility. Cimpan et al. [169] have found that 4-N,N-dimethylaminobenzoic 
acid ethyl ester (DMABEE), one of the compounds commonly being eluted, was able to cause time- 
and concentration- dependent induction of cell death in human monoblastoid cells in the form of 
apoptosis and necrosis. Other studies reported that DMABEE is also able to interact with monolayers 
of saturated phosphatidylcholines (PC, i.e., markers of the outer membrane leaflet) and 
phosphatidylserines (PS., i.e., markers of the inner membrane leaflet) [170]. 
In conclusion, several compounds eluted from dental composites’ polymerization system are able to 
significantly contribute to their cytotoxicity and genotoxicity by enhancing the oxidative stress and 
DNA damage. These effects are significantly increased by visible light irradiation of these systems.  
 
4.4. Effects of Composite Resins’ Compounds on Oral Bacteria Growth 
 
Most studies support that pulp inflammation caused by derivatives of resin composites is mainly 
due to incomplete dentin adhesion, which leads to bacterial microleakage [171-173]. However, there 
are also some studies supporting that dental monomers, such as TEGDMA and EGDMA are able to 
promote the growth and proliferation of caries relevant bacteria, such as S. Sobrinus και L. Acidophilus 
[174,175] and by this way to contribute to pulpal inflammation and secondary caries formation. Kawai 
et al. supported that these monomers are not only able to increase bacterial growth but also to increase 
glycosyltransferase activity which is responsible for glycanes formation that play a key role in 
bacterial adhesion and plaque formation. Moreover, Khalichi et al. [176] supported that several   
by-products of TEGDMA, such as TEG, are also able to increase glycosyltransferase B expression in 
S. mutans. On the contrary, Takahasi et al. [177] claimed that ethyleneglycol monomers do not Int. J. Mol. Sci. 2009, 10                 
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increase in fact microbial proliferation but the observed biomass increase is mainly due to 
polymerization of resin monomers to form vesicular structures attached to cells.  
There has also been and effort to produce resin monomers with antibacterial properties, such as 
MDPB (methacryloxydodecylpyridinium bromide) or composites fillers based on apatite and contain 
silver and zinc (ApaciderTM ή Novaron) [178-180]. Although these substances are able to reduce the 
proliferation of cariogenic bacteria including Str. Mutans, they are usually immobilized by 
polymerization and therefore diffusion through the dentin is no longer possible [179]. 
 
5. Discussion and Conclusions 
 
Studies on the molecular toxicology of substances released by resin-based dental restorative 
materials clearly support that the majority of these molecules are able to cause cytotoxic and genotoxic 
effects at concentrations relevant to those released into the oral cavity. These effects include 
irreversible disturbance of basic cellular functions, such as cell proliferation, enzyme activities, cell 
morphology, membrane integrity, cell metabolism and cell viability. Signaling pathways involved in 
immune response, tissue homeostasis and repair are also affected. Moreover, several studies have 
reported the clastogenic and genotoxic properties of some of these substances, implying their potential 
mutagenic effects and stressing the importance of assessing their safety from the viewpoint   
of genotoxicity.  
The clinical relevance of identifying the potential of these substances to disturb functions at the 
cellular and molecular level has been already emphasized by experienced investigators in the field 
[20,181]. However, the direct extrapolation of molecular toxicological data obtained from in vitro 
studies into the clinical situation is not always straight forward. At the local level, a large number of  
in vivo studies with animal or human teeth (usage tests) support that pulp reaction is not expected in 
medium or low depth cavities, when a sufficient thickness of dentin layer remains and bacterial 
penetration beneath the filling is avoided [182-185]. On the other hand, other studies support that there 
are pronounced histological reactions when the remaining dentin is too thin and acid etched [186,187]. 
The same detrimental effects, including pulp inflammation, insufficient reparative dentin formation 
and even pulp necrosis are also reported when resin adhesives are used for direct pulp capping instead 
of calcium hydroxide [188-191]. Further research on this aspect is necessary. 
The clinical significance of in vitro mutagenicity and genotoxicity data is also quite difficult to be 
assessed, since no information is up to now available concerning the threshold concentrations that are 
able to trigger these reactions during the long term clinical service of these materials. Moreover, the 
toxicokinetics of the metabolic products of dental composites and the possibility for systemic 
mutagenic effects should be further investigated in animal models.  
Although the frequency of adverse effects caused by resin based dental restorative materials, mainly 
allergic reactions in patients and dental personnel [192-195], has increased over the past years, the 
total number of patients presenting with adverse reactions still remains a low proportion of the total 
population. However, despite the fact that general risk seems to be quite low, the individual health risk 
during the long term clinical service of these materials, attributed to interindividual variations in 
immune responses and reparative processes, cannot be underestimated, especially in severe allergic 
cases [19].  Int. J. Mol. Sci. 2009, 10                 
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It is surprising however that despite the rapidly growing bulk of scientific evidence concerning the 
toxicological effects of these substances, little effort has been observed form the part of the companies 
to develop new materials not only with improved mechanical but also biological properties. The 
majority of commercially available products are based on methacrylate monomers, whereas some 
promising new technologies, including Siloranes and Ormocers [196,197], using different chemistry 
and polymerization mechanisms are yet to be investigated from the viewpoint of biocompatibility. 
Taking into account that dental composite resins have an integral role in every day dental clinical 
practice, it is extremely important to encourage not only the development of less cytotoxic materials 
but also, as a future goal, the development of “biomimetic” materials or “biofillings”, which will be 
effective in stimulating natural tissue repair and maintaining the vitality of the compromised   
oral tissues.  
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